Biological robustness in complex host-pathogen systems

Progress in Drug Research

Volumn 64, Issue , 2007, Pages 239-263

  Kitano, Hiroaki ^a,b  

^a Systems Biology Institute   (Japan)

^b SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARDIAC AGENT; LAMIVUDINE; UNCLASSIFIED DRUG; VESARIONE; ZIDOVUDINE;

AUTOIMMUNE DISEASE; BACTERIAL GROWTH; DISEASE CONTROL; DISEASE PREDISPOSITION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; GENE TRANSFER; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFECTION PREVENTION; MICROFLORA; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ADAPTATION; ANIMAL; IMMUNOLOGY; INFECTION; PHYSIOLOGY; SYMBIOSIS;

ADAPTATION, BIOLOGICAL; ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE SYSTEM; INFECTION; SYMBIOSIS;

EID: 33846903329     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7643-7567-6_10     Document Type: Review

References (103)

1. Kitano H (2004) Biological robustness. Nat Rev Genet 5(11): 826-837
2. Stelling J, Sauer U, Szallasi Z, Doyle FJ 3rd, Doyle J (2004) Robustness of cellular functions. Cell 118(6): 675-685
3. Alon U, Surette MG, Barkai N, Leibler S (1999) Robustness in bacterial chemotaxis. Nature 397(6715): 168-171
4. Barkai N, Leibler S (1997) Robustness in simple biochemical networks. Nature 387(6636): 913-917
5. Yi TM, Huang Y, Simon MI, Doyle J (2000) Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci USA 97(9): 4649-4653
6. von Dassow G, Meir E, Munro EM, Odell GM (2000) The segment polarity network is a robust developmental module. Nature 406(6792): 188-192
7. Ingolia NT (2004) Topology and robustness in the Drosophila segment polarity network. PLoS Biol 2(6): E123
8. Little JW, Shepley DP, Wert DW (1999) Robustness of a gene regulatory circuit. Embo J 18(15): 4299-4307
9. Yachi S, Loreau M (1999) Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. Proc Natl Acad Sci USA 96(4): 1463-1468
10. Wagner GP, Altenberg L (1996) Complex adaptations and the evolution of evolvability. Evolution 50(3): 967-976
11. Rutherford SL (2003) Between genotype and phenotype: protein chaperones and evolvability. Nat Rev Genet 4(4): 263-274
12. de Visser J, Hermission J, Wagner GP, Meyers L, Bagheri-Chaichian H, Blanchard J, Chao L, Cheverud J, Elena S, Fontana W et al (2003) Evolution and detection of genetics robustness. Evolution 57(9): 1959-1972
13. Gerhart J, Kirschner M (1997) Cells, embryos, and evolution: toward a cellular and developmental understanding of phenotypic variation and evolutionary adaptability. Blackwell Science, Malden, Massachusetts, USA
14. Kirschner M, Gerhart J (1998) Evolvability. Proc Natl Acad Sci USA 95(15): 8420-8427
15. Kitano H (2004) Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4(3): 227-235
16. Kitano H (2003) Cancer robustness: tumour tactics. Nature 426(6963): 125
17. Kitano H, Oda K, Kimura T, Matsuoka Y, Csete M, Doyle J, Muramatsu M (2004) Metabolic syndrome and robustness tradeoffs. Diabetes 53 Suppl 3: S6-S15
18. Tyson JJ, Chen K, Novak B (2001) Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2(12): 908-916
19. Ferrell JE Jr (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 14(2): 140-148
20. Chen KC, Calzone L, Csikasz-Nagy A, Cross FR, Novak B, Tyson JJ (2004) Integrative analysis of cell cycle control in budding yeast. Mol Biol Cell 15(8): 3841-3862
21. Agrawal AA (2001) Phenotypic plasticity in the interactions and evolution of species. Science 294(5541): 321-326
22. Schlichting C, Pigliucci M (1998) Phenotypic evolution: a reaction norm perspective. Sinauer Associates, Inc., Sunderland, MA, USA
23. Eldar A, Dorfman R, Weiss D, Ashe H, Shilo BZ, Barkai N (2002) Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature 419(6904): 304-308
24. Meir E, von Dassow G, Munro E, Odell GM (2002) Robustness, flexibility, and the role of lateral inhibition in the neurogenic network. Curr Biol 12(10): 778-786
25. Schlosser G, Wagner G (eds) (2004) Modularity in development and evolution. The University of Chicago Press, Chicago, USA
26. Rutherford SL, Lindquist S (1998) Hsp90 as a capacitor for morphological evolution. Nature 396(6709): 336-342
27. Queitsch C, Sangster TA, Lindquist S (2002) Hsp90 as a capacitor of phenotypic variation. Nature 417(6889): 618-624
28. Siegal ML, Bergman A (2002) Waddington's canalization revisited: developmental stability and evolution. Proc Natl Acad Sci USA 99(16): 10528-10532
29. Waddington CH (1957) The strategy of the genes: a discussion of some aspects of theoretical biology. Macmillan, New York, USA
30. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36(2): 147-150
31. Csete ME, Doyle J (2004) Bow ties, metabolism and disease. Trends Biotechnol 22(9): 446-450
32. Carlson JM, Doyle J (1999) Highly optimized tolerance: a mechanism for power laws in designed systems. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 60(2 Pt A): 1412-1427
33. Carlson JM, Doyle J (2002) Complexity and robustness. Proc Natl Acad Sci USA 99 Suppl 1: 2538-2545
34. Csete ME, Doyle JC (2002) Reverse engineering of biological complexity. Science 295(5560): 1664-1669
35. Bak P, Tang C, Wiesenfeld K (1988) Self-organized criticality. Physical Review A 38(1): 364-374
36. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5(2): 101-113
37. Lamport L, Shostak R, Pease M (1982) The Byzantine generals problem. ACM Transactions on Programming Language and Systems 4(3): 382-401
38. Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C (2005) Escape of intracellular Shigella from autophagy. Science 307(5710): 727-731
39. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A (1999) The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA 96(5): 2396-2401
40. Waterman SR, Holden DW (2003) Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 5(8): 501-511
41. Cossart P, Pizarro-Cerda J, Lecuit M (2003) Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions. Trends Cell Biol 13(1): 23-31
42. Hacker J, Kaper JB (2000) Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 54: 641-679
43. Groisman EA, Ochman H (1996) Pathogenicity islands: bacterial evolution in quantum leaps. Cell 87(5): 791-794
44. Waldor MK, Mekalanos JJ (1996) Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272(5270): 1910-1914
45. Merrell DS, Falkow S (2004) Frontal and stealth attack strategies in microbial pathogenesis. Nature 430(6996): 250-256
46. Dubois ME, Demick KP, Mansfield JM (2005) Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system. Infect Immun 73(5): 2690-2697
47. Blaser MJ (2005) An endangered species in the stomach. Sci Am 292(2): 38-45
48. Umehara S, Higashi H, Ohnishi N, Asaka M, Hatakeyama M (2003) Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22(51): 8337-8342
49. McCune JM (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410(6831): 974-979
50. McMichael AJ, Rowland-Jones SL (2001) Cellular immune responses to HIV. Nature 410(6831): 980-987
51. Larder BA, Kemp SD (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246(4934): 1155-1158
52. Tisdale M, Kemp SD, Parry NR, Larder BA (1993) Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci USA 90(12): 5653-5656
53. Larder BA, Kemp SD, Harrigan PR (1995) Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269(5224): 696-699
54. Dropulic B, Hermankova M, Pitha PM (1996) A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread. Proc Natl Acad Sci USA 93(20): 11103-11108
55. Weinberger LS, Schaffer DV, Arkin AP (2003) Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J Virol 77(18): 10028-10036
56. Mautino MR, Morgan RA (2002) Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes. AIDS Patient Care STDS 16(1): 11-26
57. Kitano H, Oda K (2006) Robustness trade-offs and host-microbial symbiosis in the immune system. Mol Sys Biol msb4100039-E1
58. Oda K, Kitano H (2006) A comprehensive molecular interaction map of Toll-like receptor signaling network. Mol Sys Biol msb4100057
59. Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3(5): 401-416
60. Nathan C (2002) Points of control in inflammation. Nature 420(6917): 846-852
61. O'Shea JJ, Ma A, Lipsky P (2002) Cytokines and autoimmunity. Nat Rev Immunol 2(1): 37-45
62. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ (1995) Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268(1 Pt 2): R78-84
63. Hennet T, Ziltener HJ, Frei K, Peterhans E (1992) A kinetic study of immune mediators in the lungs ofmice infected with influenza A virus. J Immunol 149(3): 932-939
64. Wyde PR, Wilson MR, Cate TR (1982) Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection. Infect Immun 38(3): 1249-1255
65. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H (1989) Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244(4907): 974-976
66. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F (1995) Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J Immunol 155(3): 1326-1333
67. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S (1994) Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation 89(3): 955-958
68. Matsui S, Matsumori A, Matoba Y, Uchida A, Sasayama S (1994) Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest 94(3): 1212-1217
69. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R (1988) Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2(8602): 72-74
70. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1991) A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. Faseb J 5(3): 338-343
71. Csete M, Doyle J (2004) Bow ties, metabolism and disease. Trends Biotechnol 22(9): 446-450
72. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353(6345): 622-627
73. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364(6432): 33-39
74. Yewdell JW, Bennink JR (2001) Cut and trim: generating MHC class I peptide ligands. Curr Opin Immunol 13(1): 13-18
75. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307(5710): 734-738
76. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307(5710): 731-734
77. Tiveljung A, Soderholm JD, Olaison G, Jonasson J, Monstein HJ (1999) Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J Med Microbiol 48(3): 263-268
78. Baum H, Davies H, Peakman M (1996) Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 17(2): 64-70
79. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9(12): 1484-1490
80. von Herrath MG, Fujinami RS, Whitton JL (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1(2): 151-157
81. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2(8618): 983-986
82. Campbell LA, Kuo CC (2004) Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2(1): 23-32
83. Haranaga S, Yamaguchi H, Friedman H, Izumi S, Yamamoto Y (2001) Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun 69(12): 7753-7759
84. Wick G, Perschinka H, Xu Q (1999) Autoimmunity and atherosclerosis. Am Heart J 138(5 Pt 2): S444-449
85. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM (1999) Chlamydia infections and heart disease linked through antigenic mimicry. Science 283(5406): 1335-1339
86. Xu J, Gordon JI (2003) Inaugural article: Honor thy symbionts. Proc Natl Acad Sci USA 100(18): 10452-10459
87. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107-133
88. Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22: 283-307
89. Macpherson AJ, Hunziker L, McCoy K, Lamarre A (2001) IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 3(12): 1021-1035
90. Macpherson AJ, Martinic MM, Harris N (2002) The functions of mucosal T cells in containing the indigenous commensal flora of the intestine. Cell Mol Life Sci 59(12): 2088-2096
91. Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 99(24): 15451-15455
92. Kitano H, Oda K (2006) Self-extending symbiosis: a mechanism for increasing robustness through evolution. Biological Theory 1(1): 61-66
93. Ushijima T, Ozaki Y (1988) Factors influencing potent antagonistic effects of Escherichia coli and Bacteroides ovatus on Staphylococcus aureus in anaerobic continuous flow cultures. Can J Microbiol 34(5): 645-650
94. Ushijima T, Ozaki Y (1986) Potent antagonism of Escherichia coli, Bacteroides ovatus, Fusobacterium varium, and Enterococcus faecalis, alone or in combination, for enteropathogens in anaerobic continuous flow cultures. J Med Microbiol 22(2): 157-163
95. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121(3): 580-591
96. Sartor RB (2005) Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 21(1): 44-50
97. Bergogne-Berezin E (2000) Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 16(4): 521-526
98. Cardinale BJ, Palmer MA, Collins SL (2002) Species diversity enhances ecosystem functioning through interspecific facilitation. Nature 415(6870): 426-429
99. Roberts MS, Garland JL, Mills AL (2004) Microbial astronauts: assembling microbial communities for advanced life support systems. Microb Ecol 47(2): 137-149
100. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53(5): 685-693
101. Sartor RB (2003) Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 19(4): 358-365
102. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M et al (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122(1): 44-54
103. Backhed F, Ley R, Sonnenburg J, Peterson D, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-1920